Predictors of Response and Survival Following Venetoclax Therapy in Relapsed/Refractory AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical and Molecular Predictors of Response and Survival Following Venetoclax Therapy in Relapsed/Refractory AML
Blood Adv 2021 Mar 09;5(5)1552-1564, M Stahl, K Menghrajani, A Derkach, A Chan, W Xiao, J Glass, AC King, AF Daniyan, C Famulare, BM Cuello, TZ Horvat, O Abdel-Wahab, RL Levine, AD Viny, EM Stein, SF Cai, M Roshal, MS Tallman, AD GoldbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.